Alterity Therapeutics Limited (ATHE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 66.25M |
| Enterprise Value | 33.25M |
| P/E Ratio | -7.2 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 33.48 |
| Price/Book Ratio | 2.21 |
| Enterprise/Revenue | 20.69 |
| Enterprise/EBITDA | -3.94 |
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -3.81 |
| Operating Margin | -5.26 |
| Return On Assets | -0.26 |
| Return On Equity | -0.3 |
| Revenue | 5.44M |
| Revenue/Share | 0.02 |
| Gross Profit | 5.31M |
| EBITDA | -14.63M |
| Net Income | -12.15M |
| Diluted EPS | -1.14 |
| Total Cash | 49.15M |
| Total Cash/Share | 0.24 |
| Total Debt | 98,350 |
| Total Debt/Equity | 0 |
| Current Ratio | 21.98 |
| Book Value Per Share | 0.27 |
| 52-Week Change | 12.13 |
| 52-Week High | 7 |
| 52-Week Low | 2.66 |
| Moving Average 50 Days | 4.33 |
| Moving Average 200 Days | 3.89 |
| Average Volume | 48,635 |
| Shares Outstanding | 9.06M |
| % Held by Institutions | 1.89 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | January 09, 2023 |